|
PF-59082 |
PLATSUL-A Aerosol |
2026-02-22 |
|
Soubeiran Chobet S.R.L |
Argentina
|
DASA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44519 |
PLATSUL - A Crema tópica |
2025-04-23 |
|
Soubeiran Chobet S.R.L |
Argentina
|
DASA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44514 |
PLATSUL - A, Gasas |
2015-04-23 |
|
Soubeiran Chobet S.R.L |
Argentina
|
Nobifarma |
Avanter, S.A. Avances Terapeuticos |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-7614 |
Intron A 5 millones UI inyectable |
2002-07-17 |
|
Plough Export Inc. (sucursal Guatemala) |
Guatemala
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-7615 |
Intron A 10 millones UI polvo y solucion para uso parenteral |
2012-07-17 |
|
Sp (brinny) Company |
Irlanda
|
Amicelco |
Bodega Farmacéutica S.A. |
Colon S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
Merigal S.A. |
Onco-servicios, S. A. |
Refasa S.A. |
Union De Farmaceuticos S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
PF-7613 |
Intron A 3 millones UI polvo y solucion para uso parenteral |
2007-07-17 |
|
Sp (brinny) Company |
Irlanda
|
Bodega Farmacéutica S.A. |
Colon S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
Merigal S.A. |
Refasa S.A. |
Union De Farmaceuticos S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29443 |
Intron-5 millones UI polvo para solucion inyectable |
2007-12-30 |
|
Sp (brinny) Company |
Irlanda
|
Bodega Farmacéutica S.A. |
Colon S.A. |
Agencias J.i. Cohen |
Lanquetin S.A. |
Refasa S.A. |
Union De Farmaceuticos S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59740 |
OXAL SPAL-L 100, 100 mg solución inyectable |
2026-07-29 |
|
SPAL Private Limited |
India
|
Bikasa |
Arael de Centro América |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59806 |
PALIT SPAL 100 mg (Paclitaxel unido a proteinas de albumina) Polvo liofilizado para suspensión inyectable |
2026-08-06 |
|
SPAL Private Limited |
India
|
Bikasa |
Arael de Centro América |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60025 |
BORT SPAL 3.5, 3.5 mg Polvo para uso parenteral |
2026-09-16 |
|
SPAL Private Limited |
India
|
Bikasa |
Arael de Centro América |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|